Previous 10 | Next 10 |
Kahn Brothers’ 13F portfolio value increased from $741M to $788M this quarter. Citigroup, ViewRay, and VOXX International were increased during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~48% of the 13F holdings. ...
ViewRay Announces Conference Call for First Quarter 2022 Financial Results to be Held After Market on May 5, 2022 PR Newswire CLEVELAND , April 21, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first...
University Hospital Agostino Gemelli Treats its 1,000th Patient Using MRIdian® MRI-Guided Radiation Therapy PR Newswire Center Becomes First MRIdian Program in Southern Europe to Reach this Treatment Milestone CLEVELAND , March 15, 2022 /PRNewswi...
ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on March 16, 2022 PR Newswire CLEVELAND , March 10, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company will host a Virtual Clinical Data Event for Investors a...
ViewRay (NASDAQ:VRAY) said a interim toxicity results from a phase 2 trial suggested favorable toxicity profile of post-prostatectomy stereotactic body radiotherapy (SBRT) for prostate cancer. The study, dubbed SCIMITAR, led by UCLA is evaluating the safety and efficacy of postopera...
First Toxicity Results from SCIMITAR Prospective Phase II Trial Signal Favorable Toxicity Profile of Post-Prostatectomy Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer Post-hoc Analysis Highlights Reduction in Gastrointestinal (GI) Toxicity with MRIdian® MRI-guide...
ViewRay Enters into Cooperation Agreement with Hudson Executive Capital PR Newswire CLEVELAND , March 9, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that it has reached an agreement with Hudson Executive Capital LP ("HEC") to appoint ...
Acibadem Group Purchases Second MRIdian® System for Acibadem Altunizade Hospital in Istanbul <legend role="h2">Leading Private Healthcare Service Institution in Turkey Expands MRI-guided Radiation Therapy Offerings</legend> PR Newswire CLEVELAND ...
Image source: The Motley Fool. ViewRay, Inc. (NASDAQ: VRAY) Q4 2021 Earnings Call Feb 24, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: ViewRay, Inc. (VRAY) Q4 2021 Earnings Call Transcript
ViewRay, Inc. (VRAY) Q4 2021 Earnings Conference Call February 24, 2022 04:30 PM ET Company Participants Matt Harrison - Director, Investor Relations Scott Drake - President and Chief Executive Officer Zach Stassen - Chief Financial Officer Paul Strong - Vice President, Clinical Affairs Confe...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...